Morales María Luz, Ferrer-Marín Francisca
Hematology and Medical Oncology Department, Hospital Universitario Morales-Meseguer, Centro Regional de Hemodonación, IMIB-Pascual Parrilla, 30120 Murcia, Spain.
CIBERER CB15/00055, 28029 Murcia, Spain.
Cancers (Basel). 2023 Feb 20;15(4):1348. doi: 10.3390/cancers15041348.
Myeloproliferative neoplasms (MPNs) arise from the uncontrolled proliferation of hematopoietic stem and progenitor cells in bone marrow. As with all tumors, the development of MPNs is a consequence of alterations in malignant cells and their interaction with other extrinsic factors that support and promote tumor progression. Since the discovery of driver mutations, much work has focused on studying and reviewing the genomic features of the disease but has neglected to delve into the important role that many other mechanisms may play. This review discusses the genetic component of MPNs but focuses mainly on some of the most relevant work investigating other non-genetic factors that may be crucial for the disease. The studies summarized here address MPN cell-intrinsic or -extrinsic factors and the interaction between them through transcriptomic, proteomic and microbiota studies, among others.
骨髓增殖性肿瘤(MPNs)起源于骨髓中造血干细胞和祖细胞的不受控制的增殖。与所有肿瘤一样,MPNs的发生是恶性细胞改变及其与支持和促进肿瘤进展的其他外在因素相互作用的结果。自发现驱动突变以来,许多工作都集中在研究和综述该疾病的基因组特征上,但却忽略了深入探讨许多其他机制可能发挥的重要作用。本综述讨论了MPNs的遗传成分,但主要关注一些研究其他可能对该疾病至关重要的非遗传因素的最相关工作。这里总结的研究通过转录组学、蛋白质组学和微生物群研究等,探讨了MPN细胞内在或外在因素以及它们之间的相互作用。